Is there still a role for ultrafiltration in the management of acute heart failure? CARRESS and beyond.

about

Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.

P2860

Q38449311-B75FC2ED-C698-499C-ABBC-F4E7535470A4

P2860

Is there still a role for ultrafiltration in the management of acute heart failure? CARRESS and beyond.

Item

http://www.wikidata.org/entity/Q38111248

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Is there still a role for ultr ...... t failure? CARRESS and beyond.

@en

type

Item

label

Is there still a role for ultr ...... t failure? CARRESS and beyond.

@en

prefLabel

Is there still a role for ultr ...... t failure? CARRESS and beyond.

@en

P1476

Is there still a role for ultr ...... t failure? CARRESS and beyond.

@en

P2093

Jason Ryan

http://www.w3.org/2001/XMLSchema#string

Stephen Meng

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure.

Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.

Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial.

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.

Congestive heart failure: pathophysiologic consequences of neurohormonal activation and the potential for recovery: part I.

Diuretics and ultrafiltration in acute decompensated heart failure.

Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.

P2888

s11897-013-0142-z

P304

185-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11897-013-0142-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1007615280

http://www.w3.org/2001/XMLSchema#string

P698

23728784

http://www.w3.org/2001/XMLSchema#string

Is there still a role for ultrafiltration in the management of acute heart failure? CARRESS and beyond.

about

P2860

P2860

Is there still a role for ultrafiltration in the management of acute heart failure? CARRESS and beyond.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698